The Reasons Behind Retractions

An analysis of 244 retraction notices shows how journals handle mistakes and fraudulent behavior.

Written byKate Yandell
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, ROBERT CUDMOREA new study of retraction notices published in numerous journals in 2008 sheds light on why papers are retracted, and how well journals and authors are handling retractions when they become necessary.

The paper, published in BMC Research Notes last week (June 19), includes an analysis of 244 retraction notices found on Medline. A total of 235 notices explained reasons for the retraction. “The most cited reasons were mistakes (28%), plagiarism (20%), fraud (14%) and overlap (11%),” the authors of the paper wrote.

The authors found the original versions or the locations where the original versions would have been of 233 of the retracted papers. Of those papers, 22 percent were available and carried no mention that they had been retracted, 18 percent had been deleted completely, and 60 percent were available with clear retraction notices.

When Retraction Watch asked University of Washington doctor and microbiologist Ferric Fang, whose own research has identified research misconduct as the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies